To the content
1 . 2022

The ability to block "metabolic memory" in patients with impaired glucose tolerance

Abstract

The progression of the pathological process of impaired glucose tolerance/or impaired fasting glycemia lasts for many years. However, patients with impaired glucose tolerance (IGT) will move to the category of patients with type 2 diabetes mellitus in certain circumstances. Do doctors have mechanisms that helps to block the "metabolic memory" of the body in real clinical practice and delay the progression of insulin resistance, endothelial dysfunction and vascular complications? The effect of a combination of metformin at a dose of 1700 mg and taurine at a dose of 1000 mg on the level of insulin resistance was evaluated from this angle in 50 patients with new-onset IGT with continuous administration of treatment for 18 months. The assessment was carried out using the coefficient of the ratio of the insulin level at the 120th minute to the level of insulin at the 0th minute (coefficient K1), the data obtained showed a high level of its information value (as an indicator of IGT). Further analysis revealed that with an increase in the insulin level at the 120th minute up to 4 times, glucose metabolism was restored in 100% of cases, and the diagnosis of IGT was withdrawn. With an increase in K1 from 4 to 7.5 times, restoration of glucose metabolism was observed in 61.1% of cases. With an increase in the K1 level by 7.5 times or more, the diagnosis of IGT remained in 71.4% of cases.

Thus, the combination of metformin at a dose of 1700 mg and taurin at a dose of 1000 mg with a change in lifestyle and an increase in exercise allows patients with impaired glucose tolerance to block "metabolic memory". The K1 coefficient discussed in this study has a high predictive ability, which makes it possible to facilitate the doctor to develop therapeutic strategies to reduce the risk of type 2 diabetes mellitus at a outpatient care.

Keywords:impaired glucose tolerance; metformin; taurine; "metabolic memory"; insulin resistance; coefficient of K1

Funding. The study had no sponsor support.

Conflict of interest. The authors declare no conflict of interest.

For citation: Manovitskaya A.V., Dubrova T.A. The ability to block «metabolic memory» in patients with impaired glucose tolerance. Endokrinologiya: novosti, mneniya, obuchenie [Endocrinology: News, Opinions, Training]. 2022; 11 (1): 17-23. DOI: https://doi.org/10.33029/2304-9529-2022-11-1-17-23 (in Russian)

REFERENCES

1. Diabetes Guidelines Based on Diabetes Atlas of the International Diabetes Federation (IDF). 9th edition. Brussels; 2019.

2. Dedov I.I., Shestakova M.V., Galstyan G.R., Prevalence of type 2 diabetes in the adult population of Russia (Nation study). Sakharni diabet [Diabetes Mellitus]. 2016; 19 (2): 104-12. DOI: https://doi.org/10.14341/DM2004116-17 (in Russian)

3. Type 2 diabetes mellitus in adults: clinical guidelines; Moscow: Russian Association of Endocrinologists; 2021. (in Russian)

4. Knowler W.C., Barrett-Connor E., Fowler S.E., et al. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 346 (6): 393-403. DOI: https://doi.org/10.1056/NEJMoa012512

5. Ametov A.S. Type 2 diabetes. Problems and solutions. 2nd ed. Moscow: GEOTAR-Media; 2013. (in Russian)

6. Demidova I. Yu., Gorokhova T.V. Mechanism of action and clinical application of metformin (Siophore): literature review. Farmateka [Pharmateca]. 2009; (17): 10-14. (in Russian)

7. Imae M., Asano T., Murakami S. Potential role of taurine in the prevention of diabetes and metabolic syndrome. Amino Acids. 2014; 46 (1): 81-8.

8. Walczewska M., Marcinkiewicz J. Taurine chloramine and its potential therapeutical application. Przegl Lek. 2011; 68 (6): 334-8.

9. Wu Q.D., Wang J.H., Fennessy F., Redmond H.P., Bouchier-Hayes D. Taurine prevents high-glucose-induced human vascular endothelial cell apoptosis. Am J Physiol. 1999; 277 (6): 1229-38.

10. Wang J.H., Redmond H.P., Watson R.W., Condron C., Bouchier-Hayes D. The beneficial effect of taurine on the prevention of human endothelial cell death. Shock. 1996; 6 (5): 331-8.

11. Schaffer S.W., Azuma J., Mozaffari M. Role of antioxidant activity of taurine in diabetes. Can J Physiol Pharmacol. 2009; 87 (2): 91-9.

12. Brons C.C., Spohr H., Storgaard J., Vaag D. Effect of taurine treatment on insulin secretion and action, and on serum lipid levels in overweight men with a genetic predisposition for type II diabetes mellitus. Eur J Clin Nutr. 2008; 86: 1239-47.

13. Kholmatova K.K., Kharkov O.A., Grzhibovsky A.M. Classification of scientific research in healthcare. Ekologiya cheloveka [Human Ecology]. 2016; (1): 57-64. (in Russian)

14. Ametov A.S., Demidova T. Yu., Mkrtumyan A.M., Dudinskaya E.N., Sizova E.E. Challenge of modern endocrinology: the search for combination therapy in insulin resistance (lecture). Endokrinologiya: novosti, mneniya, obuchenie [Endocrinology: News, Opinions, Training]. 2020; 9 (1): 60-9. DOI: https://doi.org/10.33029/2304-9529-2020-9-1-60-69 (in Russian)

15. Grzhibovsky A.M. Analysis of nominal data (independent observations). Ekologiya cheloveka [Human Ecology]. 2008; (6): 58-68. (in Russian)

16. Mayorov A.Yu., Urbanova K.A., Galstyan G.R. Methods for guantificative assessment of insulin resistance. Obesity and Metabolism. 2009; 2: 19-23. DOI: https://doi.org/10.14341/2071-8713-5313 (in Russian)

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

CHIEF EDITOR
CHIEF EDITOR
Ametov Alexander S.
Honored Scientist of the Russian Federation, Doctor of Medical Sciences, Professor, Head of Subdepartment of Endocrinology, Head of the UNESCO Network Chair on the subject «Bioethics of diabetes as a global problem» of the Russian Medical Academy of Continuous Professional Education (Moscow)
Вскрытие

Journals of «GEOTAR-Media»